本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

14.22
+0.46003.34%
盘后14.21-0.0100-0.07%19:53 EDT
成交量:206.13万
成交额:2,932.67万
市值:16.95亿
市盈率:-13.67
高:14.53
开:13.99
低:13.88
收:13.76
数据加载中...
2024/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities